UK biotech companies are developing new therapies for cancer, Parkinson’s, diabetes and tinnitus as a direct result of the £100 …
A £180 million government fund to help innovative small and medium sized enterprises (SMEs) and academics to develop solutions to …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

